Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using spinal cord stimulation to treat diabetic peripheral neuropathy

Official title: A Novel Neuromodulation Approach to Target Small Fiber Neuropathy Early in Diabetes and Measure Functional Recovery

Run by Ohio State University · NCT06287736 · Data updated 2026-11-12

This study is testing if spinal cord stimulation can help people with diabetic peripheral neuropathy feel less pain and improve their nerve health.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorOhio State University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedApril 17, 2024
Main results expectedFebruary 1, 2028
Study endsJuly 3, 2028
Registry record updatedJuly 23, 2026
Trial IDNCT06287736 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with diabetic peripheral neuropathy that has not responded to standard treatments.

Probably not a fit

Patients with severe medical comorbidities or those who cannot undergo surgical intervention may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial is a prospective randomized control trial that aims to evaluate the effectiveness of spinal cord stimulation (SCS) in treating diabetic peripheral neuropathy (DPN). Participants will be randomly assigned to one of three groups: two treatment groups receiving SCS and one control group. The study will measure pain levels, DPN severity, small fiber nerve activity, and metabolic health markers before and after the SCS treatment. The goal is to gather more information on the diagnosis and treatment of DPN using SCS.

Why it matters

Potential benefit: If successful, this study could provide a new effective treatment option for patients suffering from diabetic peripheral neuropathy.

How similar studies have gone: Previous studies have shown that spinal cord stimulation can be effective in treating chronic pain, including diabetic peripheral neuropathy, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Over 18 years old
* Diagnosis of diabetic peripheral neuropathy refractory to treatment with gabapentin or pregabalin and at least 1 other class of analgesic
* Diagnosis of medically refractory pain secondary to diabetic neuropathy
* Presence of pain for 12 months
* Lower limb pain intensity score ≥4 on a visual analog scale
* DN4 ≥4
* Pass pre-operative neuropsychological assessment (surgical group only)
* Capable of providing informed consent

Exclusion Criteria:

* Severe medical comorbidities that, in the opinion of the surgeon, exclude the patient from surgical intervention
* Spinal disease with severe spinal stenosis or spinal cord compression in the region of the proposed spinal cord stimulator lead placement
* Coagulopathy that cannot be corrected
* Unable to discontinue blood thinning medications
* Hemoglobin A1c level greater than 10
* Presence of systemic infection
* Pregnancy

Where it's running

  • The Ohio State University Wexner Medical Center
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.